Two Sigma Advisers LP Sells 40,600 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Two Sigma Advisers LP lowered its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 70.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 17,000 shares of the company's stock after selling 40,600 shares during the period. Two Sigma Advisers LP's holdings in Pediatrix Medical Group were worth $223,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Parkside Financial Bank & Trust lifted its position in shares of Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock worth $51,000 after purchasing an additional 1,040 shares in the last quarter. Nomura Asset Management Co. Ltd. raised its position in shares of Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock valued at $33,000 after purchasing an additional 1,220 shares during the period. AlphaQuest LLC raised its holdings in Pediatrix Medical Group by 65.9% in the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock valued at $66,000 after acquiring an additional 2,012 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Pediatrix Medical Group by 6.1% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 49,002 shares of the company's stock worth $643,000 after buying an additional 2,801 shares during the period. Finally, Illinois Municipal Retirement Fund lifted its position in shares of Pediatrix Medical Group by 7.8% during the 4th quarter. Illinois Municipal Retirement Fund now owns 47,409 shares of the company's stock valued at $622,000 after acquiring an additional 3,411 shares during the period. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Stock Performance

Shares of NYSE MD traded up $0.01 during trading on Tuesday, reaching $14.14. 606,662 shares of the stock traded hands, compared to its average volume of 819,882. The company has a 50-day moving average of $13.64 and a 200-day moving average of $14.00. Pediatrix Medical Group, Inc. has a 52-week low of $6.62 and a 52-week high of $17.67. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The stock has a market capitalization of $1.21 billion, a P/E ratio of -11.78, a price-to-earnings-growth ratio of 1.74 and a beta of 1.27.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.08. The business had revenue of $458.36 million during the quarter, compared to analyst estimates of $451.44 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. Pediatrix Medical Group's revenue for the quarter was down 7.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.20 earnings per share. Analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on MD shares. Truist Financial reduced their target price on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a report on Friday, April 11th. Macquarie lifted their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. Finally, UBS Group lowered their target price on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a research note on Monday, May 12th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, Pediatrix Medical Group currently has a consensus rating of "Hold" and a consensus price target of $16.67.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.